IL162383A0 - Streptococcus pneumoniae vaccine - Google Patents

Streptococcus pneumoniae vaccine

Info

Publication number
IL162383A0
IL162383A0 IL16238302A IL16238302A IL162383A0 IL 162383 A0 IL162383 A0 IL 162383A0 IL 16238302 A IL16238302 A IL 16238302A IL 16238302 A IL16238302 A IL 16238302A IL 162383 A0 IL162383 A0 IL 162383A0
Authority
IL
Israel
Prior art keywords
streptococcus pneumoniae
pneumoniae vaccine
vaccine
streptococcus
pneumoniae
Prior art date
Application number
IL16238302A
Other languages
English (en)
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of IL162383A0 publication Critical patent/IL162383A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16238302A 2001-12-18 2002-12-18 Streptococcus pneumoniae vaccine IL162383A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0130215.7A GB0130215D0 (en) 2001-12-18 2001-12-18 Vaccine
PCT/EP2002/014476 WO2003051392A2 (en) 2001-12-18 2002-12-18 Streptococcus pneumoniae vaccine

Publications (1)

Publication Number Publication Date
IL162383A0 true IL162383A0 (en) 2005-11-20

Family

ID=9927830

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16238302A IL162383A0 (en) 2001-12-18 2002-12-18 Streptococcus pneumoniae vaccine

Country Status (19)

Country Link
US (1) US20050214329A1 (ru)
EP (1) EP1463519A2 (ru)
JP (1) JP2005516932A (ru)
KR (1) KR20040074091A (ru)
CN (1) CN1635904A (ru)
AU (1) AU2002361007A1 (ru)
BR (1) BR0215089A (ru)
CA (1) CA2470645A1 (ru)
CO (1) CO5590937A2 (ru)
GB (1) GB0130215D0 (ru)
HU (1) HUP0402471A3 (ru)
IL (1) IL162383A0 (ru)
IS (1) IS7297A (ru)
MX (1) MXPA04006073A (ru)
NO (1) NO20043018L (ru)
PL (1) PL370804A1 (ru)
RU (1) RU2004117775A (ru)
WO (1) WO2003051392A2 (ru)
ZA (1) ZA200404803B (ru)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763244B1 (fr) 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc Composition vaccinale multivalente a porteur mixte
CN104815327A (zh) 2005-04-08 2015-08-05 惠氏有限责任公司 多价肺炎球菌多糖-蛋白质缀合物组合物
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
AU2011253684B8 (en) * 2005-04-08 2013-07-11 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
CA2808919C (en) 2005-12-22 2016-04-19 Glaxosmithkline Biologicals S.A. Streptococcus pneumoniae capsular saccharide vaccine
AU2012216698B2 (en) * 2005-12-22 2014-03-06 Glaxosmithkline Biologicals Sa Pneumococcal polysaccharide conjugate vaccine
WO2007127668A2 (en) * 2006-04-26 2007-11-08 Wyeth Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
WO2008022302A2 (en) * 2006-08-17 2008-02-21 The Uab Research Foundation Immunogenic pcpa polypeptides and uses thereof
CN1971275B (zh) * 2006-12-06 2012-07-04 云南沃森生物技术股份有限公司 肺炎链球菌6b型、18c型、19f型、23f型多糖结合物中游离多糖含量的测定方法
UY31064A1 (es) * 2007-05-02 2009-01-05 Glaxosmithkline Biolog Sa Vacuna
DK2167121T3 (en) * 2007-06-26 2015-11-23 Glaxosmithkline Biolog Sa A vaccine comprising Streptococcus pneumoniae kapselpolysaccharidkonjugater
KR101595234B1 (ko) * 2007-07-23 2016-02-26 사노피 파스퇴르 리미티드 면역원성 폴리펩타이드 및 단일클론 항체
US20160228500A9 (en) * 2007-07-23 2016-08-11 Martina Ochs Immunogenic Polypeptides and Monoclonal Antibodies
GB201003924D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
US9944680B2 (en) 2010-12-03 2018-04-17 Sandfi Pasteur Limited Composition for immunization against Streptococcus pneumoniae
JP6042455B2 (ja) * 2012-01-30 2016-12-14 セラム インスティチュート オブ インディア プライベイト リミテッド 免疫原性組成物の調製方法
CA2888321A1 (en) * 2012-10-17 2014-04-24 Glaxosmithkline Biologicals S.A. Immunogenic composition
US20140105927A1 (en) * 2012-10-17 2014-04-17 Glaxosmithkline Biologicals S.A. Immunogenic composition
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
CN106109486A (zh) * 2015-07-06 2016-11-16 北京科兴中维生物技术有限公司 一种组合物及其制备方法与应用
CA3052621A1 (en) 2017-02-03 2018-08-09 Schadeck, Eva Barbara Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
KR20240018697A (ko) 2017-06-10 2024-02-13 인벤트프라이즈 인크. 면역원성과 항원항체 결합성이 개선된 2가 또는 다가 접합체 다당류를 가진 다가 접합체 백신
IL304977A (en) 2018-02-05 2023-10-01 Sanofi Pasteur Inc A multivalent pneumococcal protein-polysaccharide conjugate preparation
BR112020021296A2 (pt) * 2018-04-18 2021-01-26 Sk Bioscience Co., Ltd. polissacarídeo capsular de streptococcus pneumoniae e conjugado imunogênico do mesmo

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811102A (en) * 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
FR2763244B1 (fr) * 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc Composition vaccinale multivalente a porteur mixte
CA2365296A1 (en) * 1999-03-19 2000-09-28 Pierre Michel Desmons Vaccine

Also Published As

Publication number Publication date
NO20043018L (no) 2004-07-15
CO5590937A2 (es) 2005-12-30
WO2003051392A2 (en) 2003-06-26
KR20040074091A (ko) 2004-08-21
HUP0402471A3 (en) 2005-04-28
GB0130215D0 (en) 2002-02-06
HUP0402471A2 (hu) 2005-03-29
EP1463519A2 (en) 2004-10-06
AU2002361007A1 (en) 2003-06-30
MXPA04006073A (es) 2005-03-31
BR0215089A (pt) 2004-11-16
US20050214329A1 (en) 2005-09-29
PL370804A1 (en) 2005-05-30
WO2003051392A3 (en) 2003-11-13
CA2470645A1 (en) 2003-06-26
ZA200404803B (en) 2005-08-29
IS7297A (is) 2004-06-03
RU2004117775A (ru) 2005-04-20
CN1635904A (zh) 2005-07-06
JP2005516932A (ja) 2005-06-09

Similar Documents

Publication Publication Date Title
IL162383A0 (en) Streptococcus pneumoniae vaccine
GB0107658D0 (en) Streptococcus pneumoniae
HK1043728A1 (en) Vaccine against streptococcus pneumoniae
AU2002351623A8 (en) Streptococcus antigens
IL153558A0 (en) Streptococcus antigens
AU2003299535A8 (en) Group b streptococcus vaccine
IL164242A0 (en) Protein-based streptococcus pneumoniae vaccines
HUP0402259A3 (en) Vaccines
GB0407935D0 (en) Vaccine
IL157498A0 (en) Vaccine
EP1423141A4 (en) VACCINE
EP1381344A4 (en) NEW VACCINE
GB0121171D0 (en) Vaccine
AU7193501A (en) Multiple antigenic peptides immunogenic against streptococcus pneumoniae
GB9928678D0 (en) Streptococcus pneumoniae antigens
GB2370770B (en) Uses of Streptococcus Vaccines
GB0105238D0 (en) Vaccines
GB0026333D0 (en) Streptococcus antigens
GB0028727D0 (en) Streptococcus antigens
GB0105640D0 (en) Streptococcus proteins
GB0115496D0 (en) Vaccine
GB0128312D0 (en) Vaccine
GB0124137D0 (en) Vaccine
GB0106589D0 (en) Vaccine
GB0103867D0 (en) Vaccine